Core Points - Acadia Healthcare Company, Inc. is under investigation for potential violations of federal securities laws, leading to a significant drop in its stock price [1][3] - The company received requests for information from the U.S. Attorney's Office and a grand jury subpoena related to its patient admissions and billing practices [2] - Acadia agreed to pay $19.85 million to settle allegations of submitting false claims to Medicare and Medicaid for services that were not medically necessary [2] Company Overview - Acadia Healthcare is one of the largest for-profit chains of psychiatric hospitals in the United States [1] - The company has faced scrutiny for its practices between 2014 and 2017, with reports indicating that some of these practices continue today [2] Stock Performance - Following the news of the investigations and settlement, Acadia's stock price fell by more than 17% during morning trading on September 27, 2024 [3]
ACHC SHAREHOLDER ALERT: Acadia Healthcare Company is Under Investigation for Securities Fraud after 17% Stock Drop; Investors are Urged to Contact BFA Law (Nasdaq:ACHC)